Translating Platform Life Science Technology into Products

10/26/2016

When: Wednesday, October 26, 2016
1:00 PM
Where: The Broad Institute
415 Main Street
Monadnock
Cambridge, Massachusetts  02142
United States
Contact:
Jeremy Bond (Sign in to view e-mail address)

Event Details
Translating Platform Life Science Technology into Products



The last few years have seen accelerating deployment of platform technologies, rapidly moving groundbreaking technologies from basic research laboratories to companies.  At the same time, the bio/pharm industry has undergone significant structural changes that have enabled new opportunities for platform technologies.

Please join us for a unique perspective on the journey from concept to commercialization of platform technologies.  Three panels will discuss different stages of the journey, and how these stages have evolved over recent years.   The First Panel of
 George Church  Maryanne Fenerjian George Church (Harvard Medical School) Maryanne Fenerjian (Harvard Office of Technology Development)   will cover the academic perspective, from inception within laboratories through to outlicensing, including founding spin-out companies.
 
The Second Panel of
 Steve Bossone  Melissa Rones Steve Bossone (Alnylam Pharmaceuticals) Melissa Rones (Ropes & Gray)   will discuss IP aggregation & licensing strategies from a development perspective.     The Third Panel of
 Replacement Panelist
Stuart Pollard (Sanofi Sunrise)  will replace Kathy Bowdish in Panel 3.    Katherine Bowdish  Gerald Sewack Stuart Pollard (Sanofi Sunrise) Gera ld Sewack (RA Capital Management)    will conclude with a buy-side discussion, addressing what factors influence investment decisions, how technologies are analyzed, and the evolution of the venture and strategic investment environment.   Detailed Agenda   1:00 – 1:30:  Registration 1:30 – 2 30:  Panel 1 – Academic Perspective   A conversation with George Church and Maryanne Fenerjian about the recent history of translating/licensing platform technologies from the lab to the commercial entities   2:30 – 2:45:  Q&A with the audience & Panel 1 2:45 – 3:00:  Coffee and tea break 3:00 – 3:45:  Panel 2 - Development Perspective   A moderated conversation with Steve Bossone and Melissa Rones discussing IP strategy and how it affects transaction terms   3:45 – 4:30:  Panel 3 - Buy-side Perspective   A moderated conversation with Stuart Pollard & Jerry Sewack discussing how technologies are evaluated from the perspective of strategic and financial investors   4:30 – 5:00:  Q&A with the audience & Panels 2 & 3   5:00 – 6:00:  Continued discussions over drinks     Organized by BPLA Business & Marketplace Committee For more information, please contact Daniel Lev & Jeremy Bond, Co-Chairs Business & Marketplace Committee
businessandmarket@bpla.org   We greatly appreciate the generous support of the law firms Nutter, Pierce Atwood, and Ropes & Gray. `